MacroGenics, Inc. (MGNX)
4.17
-0.08
(-1.88%)
USD |
NASDAQ |
May 18, 11:49
MacroGenics EPS Diluted (Quarterly) : -0.5796 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Gilead Sciences, Inc. | 1.612 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.77M |
| Revenue (Quarterly) | 20.78M |
| Total Expenses (Quarterly) | 57.55M |
| Enterprise Value | 221.14M |
| Gross Profit Margin (Quarterly) | 46.01% |
| Profit Margin (Quarterly) | -177.0% |
| Earnings Yield | -26.66% |
| Normalized Earnings Yield | -26.65 |